Stock Markets June 29, 2026 02:06 PM

Market Movers: Applied Materials Leads Monday Gains as Tech, Aerospace and Biotech Stocks Shift

Semiconductor, cybersecurity and communications names top the list of Monday's largest percentage moves while select small-caps swing on analyst notes and clinical trial news

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
AMAT PANW LRCX STX

Monday's trading session produced pronounced moves across market-cap ranges, with Applied Materials and Palo Alto Networks among the largest gainers and SanDisk posting one of the larger declines. The list of notable movers spans mega-caps, large-caps, mid-caps and small-caps, and includes company-specific drivers called out alongside the percentage moves.

Market Movers: Applied Materials Leads Monday Gains as Tech, Aerospace and Biotech Stocks Shift
AMAT PANW LRCX STX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Applied Materials and Lam Research logged double-digit and high single-digit gains among mega-cap semiconductor equipment names, highlighting strong percentage moves in the sector.
  • Palo Alto Networks and Cerebras were among top gainers in the technology and cybersecurity/AI-inference-related spaces, while Seagate climbed despite one storage name, SanDisk, registering a decline.
  • Mid-cap and small-cap lists show sizeable swings; several moves include annotations tied to analyst actions or clinical-trial outcomes that coincide with the listed percentage changes.

Market activity on Monday featured a number of notable percentage changes among both large and small publicly traded companies. Movements ranged from double-digit increases in several semiconductor and technology-linked names to declines in pockets of the storage and biotech space. Below is a sector-agnostic catalog of the biggest stock movers by market-cap segment, including context where provided.

Mega-Cap Movers (Market Cap: $200 billion USD or higher)

  • Applied Materials (AMAT) +11.31%
  • Palo Alto Networks (PANW) +7.86%
  • Lam Research Corp (LRCX) +8.38%
  • Seagate Technology (STX) +8.28%
  • SanDisk Corp-Exch (SNDK) -4.62%

The mega-cap roster shows substantial upside for several equipment and cybersecurity names, with one notable storage name in decline.

Large-Cap Stock Movers (Market Cap: $10-$200 billion USD)

  • Cerebras Systems Inc (CBRS) +17.86%

Among large-caps, Cerebras posted a strong percentage increase.

Mid-Cap Stock Movers (Market Cap: $2-$10 billion USD)

  • Iridium Communications (IRDM); William Blair downgrades Iridium stock rating on Rocket Lab acquisition +23.76%
  • Colonnade Acquisition (OUST) +23.58%
  • TSLL (TSLL) +15.59%
  • Planet Labs PBC (PL) +14.26%
  • ACM Research Inc (ACMR) +12.89%
  • Fly Leasing Ltd (FLY) +12.8%

Several mid-cap names climbed by double digits. For Iridium, the itemized line includes a firm note tied to a Rocket Lab acquisition and a related analyst action; despite the downgrade language, the stock registered a sizable percentage advance on Monday.

Small-Cap Stock Movers (Market Cap: $300 million - $2 billion USD)

  • CF Acquisition V (SATL); Freedom Broker upgrades Satellogic stock rating to buy on resilient fundamentals +19.59%
  • Swarmer Inc (SWMR) +19.97%
  • Churchill Capital XI (CCXI) +17.24%
  • Evommune (EVMN); Evommune’s EVO756 fails phase 2b trial in chronic urticaria -39.48%

Small-cap action included both upgrade-driven strength for SATL and a steep pullback for Evommune after the reported phase 2b trial result for EVO756 in chronic urticaria.

Takeaways

  • Movers on Monday span market-cap categories, with particularly large percentage increases in several semiconductor, hardware and specialist technology names and pronounced weakness in a biotech small-cap.
  • Some moves carry explicit catalysts noted alongside the price change - for example, an analyst downgrade mentioned in the Iridium line and an analyst upgrade noted in the Satellogic line - while other moves are presented without an accompanying driver.

This account lists the largest percentage stock movers observed on Monday by market-cap tier and reproduces the company-level moves and the explanatory notes provided in each line.

Risks

  • Analyst actions and acquisition-related commentary can produce large share-price volatility in affected stocks - relevant to communications, aerospace and mid-cap names such as Iridium.
  • Clinical-trial failures can trigger steep downside moves for biotech small-caps, as seen with Evommune's reported phase 2b outcome and the associated share decline.
  • Upgrades and downgrades by brokers or analysts may not align with immediate price direction, creating uncertainty for investors in the short term across multiple sectors.

More from Stock Markets

Options Activity in NioCorp Jumps to Over 16,000 Contracts, Calls Dominate Volume Jun 29, 2026 Polestar's U.S. Halt Raises Questions Over Long-Term Service and Resale Support Jun 29, 2026 Options Activity in Gap Surges as Shares Slide Over 7% Jun 29, 2026 JPMorgan Finds Limited Demand for $775 Million Sable Offshore Loan Despite High Coupon Jun 29, 2026 Bernstein Flags Select Winners in Life Science Tools Amid Signs of Recovery Jun 29, 2026